The DOI matches its Crossref record; 140 of the 148 references it cites were found in a registry or an index; none of the 31 sources its claims cite is checked for support yet.
Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis
Open accessAbstract
A large array of studies have investigated peripheral oxytocin (OT) and vasopressin (ADH) as potential biomarkers of psychiatric disorders, with highly conflicting and heterogenous findings. We searched Web of KnowledgeSM and Scopus® for English original articles investigating OT and/or ADH levels in different biological fluids (plasma/serum, saliva, urine and cerebrospinal fluid) across several psychiatric disorders. Sixty-four studies were included. We conducted 19 preliminary meta-analyses addressing OT alterations in plasma/serum, saliva, urine and cerebrospinal fluid of 7 psychiatric disorders and ADH alterations in plasma/serum, saliva, urine and cerebrospinal fluid of 6 psychiatric disorders compared to controls. Hedge's g was used as effect size measure, together with heterogeneity analyses, test of publication biases and quality control. None of them (except serum OT in anorexia nervosa) revealed significant differences. There is no convincing evidence that peripheral ADH or OT might be reliable biomarkers in psychiatric disorders. However, the lack of significant results was associated with high methodological heterogeneity, low quality of the studies, small sample size, and scarce reliability of the methods used in previous studies, which need to be validated and standardized.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic review and preliminary meta-analysis found no convincing evidence that peripheral oxytocin or vasopressin levels are reliable biomarkers across psychiatric disorders. The only Bonferroni-corrected significant difference was lower serum oxytocin in anorexia nervosa, amid high heterogeneity and methodological limitations.
Key findings
- Across 19 preliminary meta-analyses, none except serum OT in anorexia nervosa showed significant differences after correction: AN serum OT n=2, overall sample=71, Hedges’ g=−0.824, 95% CI −1.308 to −0.341, p corr=0.001.
- Several uncorrected signals did not survive Bonferroni correction: CSF OT in OCD g=0.599 (p unc=0.004, p corr=ns); CSF ADH in AN g=0.922 (p unc=0.008, p corr=ns); CSF ADH in OCD g=0.601 (p unc=0.003, p corr=ns); plasma ADH in psychosis g=−0.554 (p unc=0.008, p corr=ns); salivary OT in ASD g=−0.354 (p unc=0.046, p corr=ns).
- Heterogeneity was often substantial or considerable, e.g. plasma OT in ASD Q=64.613, I²=93.81, p<0.001; plasma ADH in psychosis Q=55.984, I²=82.14, p<0.001.
- In psychosis plasma ADH, extraction technique mattered: extracted studies n=6, overall sample=220, Hedges’ g=−1.099, 95% CI −1.617 to −0.581, p=0.001, Q=13.626, I²=63.31, p=0.018.
Methods
- Systematic search of Web of Knowledge and Scopus until March 1, 2015, plus manual reference search; English original articles with ICD/DSM psychiatric diagnosis, healthy comparison group, and peripheral OT/ADH in plasma/serum, saliva, urine, or CSF; MOOSE guidelines adopted.
- Sixty-four studies were included (final database 64 samples); 19 preliminary meta-analyses were performed; diagnoses with only one study available were not meta-analyzed.
- Hedges’ g effect sizes with random-effects models, Bonferroni correction (0.05 divided by number of meta-analyses), Q and I² heterogeneity, Duval and Tweedie trim-and-fill publication bias testing, sensitivity analyses, and adapted Newcastle-Ottawa Scale quality assessment.
Limitations
- The paper states subgroups were very small, studies were highly heterogeneous, and confounders were common: 38% of included studies reported lithium salts, 42/62 (68%) failed to control for alcohol intake, 70% (35/50) did not ascertain pregnancy, and only 18% of OT studies and no ADH studies analyzed menstrual cycle fluctuations; meta-regressions were not possible due numerical constraints.
- The paper states study quality was low: Newcastle-Ottawa Scale scores ranged from 1 to 7, median 4 out of 9, and meta-analytical estimates were preliminary with high uncertainty.
- Evident from the text: many meta-analyses pooled only 2 studies; urine and saliva ADH meta-analyses were not performed because insufficient data were retrieved; the effect of NOS scores on findings could not be directly assessed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 31 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Psychosis (n ¼8, overall sample ¼691, Hedges' g¼ À0.005, 95% CI from À0.304 to 0.294, p unc ¼0.974, substantial between studies heterogeneity Q ¼24.923,I 2 ¼ 71.91, p¼ 0.001)”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 3.2.2. OT levels in plasma/serum
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BN (n¼ 2, overall sample¼86, Hedges' g¼ À0.219, 95% CI from À 0.755 to 0.318, p unc¼0.425, between studies heterogeneity non-significant)”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 3.2.1. OT levels in CSF
Strength:plain· not yet calibratedn = 2Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“OT levels in saliva of ASD were not statistically different from those observed in healthy controls (n ¼2, overall sample ¼152, Hedges' g¼ À0.354, 95% CI from À 0.701 to À 0.006, p unc¼ 0.046, p corr ¼ ns, between studies heterogeneity non significant).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 3.2.3. OT levels in saliva
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Patients with AN had lower serum OT levels than healthy comparisons (n¼ 2, overall sample ¼71, Hedges' g¼ À0.824, 95% CI from À 1.308 to À 0.341, p corr¼ 0.001, between studies heterogeneity non-significant).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 3.2.2. OT levels in plasma/serum
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found no differences between healthy comparisons and AN (n¼2, overall sample¼52, Hedges' g¼ À0.034, 95% CI from À 1.068 to 1.019, p unc¼0.950, between studies heterogeneity non-significant)”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 3.2.1. OT levels in CSF
Strength:plain· not yet calibratedn = 2Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Psychosis (n¼3, overall sample¼147, Hedges' g¼0.287, 95% CI from À 0.330 to 0.903, p unc¼ 0.362, substantial between studies heterogeneity Q¼6.482,I 2 ¼69.14, p¼0.039)”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 3.2.1. OT levels in CSF
Strength:plain· not yet calibratedn = 3Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“OCD (n¼ 2, overall sample¼99, Hedges' g¼0.599, 95% CI from 0.194 to 1.004, p unc¼0.004, p corr¼ns, between studies heterogeneity non-significant)”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 3.2.1. OT levels in CSF
Strength:plain· not yet calibratedn = 2Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“MDD (n¼ 2, overall sample¼75, Hedges' g¼ À0.333, 95% CI from À0.781 to 0.114, p unc¼0.144, between studies heterogeneity non-significant)”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 3.2.1. OT levels in CSF
Strength:plain· not yet calibratedn = 2Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“ASD (n ¼4, overall sample ¼404, Hedges' g¼ À0.576, 95% CI from À 1.442 to 0.291, p unc ¼0.193, considerable between studies heterogeneity Q¼ 64.613,I 2 ¼93.81, p o0.001)”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 3.2.2. OT levels in plasma/serum
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesA result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BD (n¼ 3, overall sample ¼275, Hedges' g¼ 0.056, 95% CI from À 0.845 to 0.957, p unc ¼0.903, considerable between studies heterogeneity Q ¼20.796,I 2 ¼90.38, po 0.001)”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 3.2.2. OT levels in plasma/serum
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 16
- Probably not a substantial claim. 23
- The quote only partly states this claim. 2
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Psychosis (n¼ 11, overall sample ¼630, Hedges' g¼ À0.554, 95% CI from À 0.966 to À 0.142, p unc ¼0.008, p corr ¼ns, considerable between studies heterogeneity Q ¼55.984,I 2 ¼ 82.14, p o0.001)”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 3.3.2. ADH levels in plasma/serum
Strength:plain· not yet calibratedn = 11Tests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Average plasmatic levels within studies included in the present meta-analysis ranged from 0.64 pg/mL to 436.97 pg/mL for OT and from 0.66 pg/mL to 109.17 pg/mL for ADH”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.1. Reliability of assays
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Study quality scores ranged from 1 to 7 (median score was 4 out of 9 possible points).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 3.4. Quality assessment
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Results were Bonferroni-corrected for multiple testing, by dividing 0.05 by the overall number of meta-analyses conducted.”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 2.2.1. Effect size
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
In the paper
“Publication biases were tested with the Duval and Tweedie”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 2.2.2. Heterogeneity, publication biases, sensitivity analysis
What the sources say
- Not checked yetcites Duval and Tweedie, 2000 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“We conducted other sensitivity analyses to investigate the putative influence of several categorical moderators: assay technique, pregnancy, alcohol use and phase of the psychotic disorder.”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 2.2.2. Heterogeneity, publication biases, sensitivity analysis
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“To further assess the robustness of the results, we performed sensitivity analyses by sequentially removing each study and re-running the analysis, when at least 5 studies were included (Higgins and Green, 2011).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 2.2.2. Heterogeneity, publication biases, sensitivity analysis
What the sources say
- Not checked yetcites Higgins and Green, 2011
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“To achieve high quality of reporting we adopted MOOSE guidelines (Stroup et al., 2000)”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 2.1.1. Search strategies
What the sources say
- Not checked yetcites Stroup et al., 2000 source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“As meta-analysis of observational studies is supposed to be characterized by significant heterogeneity, random effect models were used (Cooper et al., 2009).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 2.2.2. Heterogeneity, publication biases, sensitivity analysis
What the sources say
- Not checked yetcites Cooper et al., 2009
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“We performed an additional sub-group analysis dividing First Episode Psychosis (FEP) and chronic Psychosis vs healthy comparisons”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 2.2.2. Heterogeneity, publication biases, sensitivity analysis
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Discrepancies were resolved through consensus with a third researcher [MR].”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 2.1.1. Search strategies
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Heterogeneity among study point estimates was assessed using Q statistics (Paulson and Bazemore, 2010) and the proportion of the total variability in the effect size estimates evaluated with the I 2 index (Lipsey and Wilson, 2000).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 2.2.2. Heterogeneity, publication biases, sensitivity analysis
What the sources say
- Not checked yetcites Paulson and Bazemore, 2010 source
- Not checked yetcites Lipsey and Wilson, 2000
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the lack of significant results was associated with high methodological heterogeneity, low quality of the studies, small sample size, and scarce reliability of the methods used in previous studies”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“quality of reporting criterion (adapted Newcastle-Ottawa Scale http:// www.ohri.ca/programs/clinical_epidemiology/oxford.asp, see Supplementary material for detail)”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 2.1.4. Recorded variables
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Meta-analyses were not performed as insufficient data were retrieved.”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 3.2.4. OT levels in urine
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“A two-step literature search was conducted by two independent researchers [GR, AS].”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 2.1.1. Search strategies
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Both the commercially available immunoassays (RIA and EIA) have high heterogeneity and questionable validity (McCullough et al., 2013).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.1. Reliability of assays
What the sources say
- Not checked yetcites McCullough et al., 2013 source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“During pregnancy dramatic structural and functional changes occur in the OT system of the mother's brain (Hillerer et al., 2014;Rocchetti et al., 2014).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.8. Limitations
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Again these results indicate that peripheral OT and ADH levels are not reliable biomarkers of BD/MDD.”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.6. BD and MDD
Load-bearingStrength:hedged· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“These findings are characterized by high heterogeneity, various methodological limitations, and poor quality.”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 5. Conclusions
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Several confounding factors might have had an impact on the results.”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.8. Limitations
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✗ Checkable: fails✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. It may be too vague to check against evidence. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“our results do not contradict the potential role of the two neuropeptides in mental disorders per se but do clearly suggest that peripheral levels do not reliably distinguish cases from controls.”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4. Discussion
Load-bearingStrength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Meta-analyses were not performed as insufficient data were retrieved.”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 3.2.4. OT levels in urine
Strength:plain· not yet calibratedTests✗ Asserted: fails✓ Checkable: passes✗ Load-bearing: fails✗ Based: failsProbably not a substantial claim. The authors may not put it forward as true. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. The quote only partly states this claim.
None of the sources cited for this claim have been checked yet.
In the paper
“There is considerable evidence of a role these two neuropeptides in various aspects of social behaviour.”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.4. Psychosis
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“a body of literature that has demonstrated a role for these neuropeptides in functions which map on to common symptoms and behavioural deficits in psychosis and schizophrenia, in particular in the social cognition domain (MacDonald and MacDonald, 2010).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.4. Psychosis
What the sources say
- Not checked yetcites MacDonald and MacDonald, 2010 source
Strength:boosted· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As a consequence, our meta-analytical estimates are affected by high uncertainty and should be considered as a preliminary synthesis of the available literature.”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.8. Limitations
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As the present analysis investigates between-group differences, not within-group effects our results do not contradict the potential role of these neuropeptides in the symptoms of psychosis per se.”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.4. Psychosis
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“No significant publication bias emerged.”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 3.3.4. Publication bias and sensitivity analyses
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
None of the sources cited for this claim have been checked yet.
In the paper
“As regard OT, preclinical studies in rats found that a systemic injection of lithium leads to a significant elevation of peripheral OT levels (Cui et al., 2001;You et al., 2001).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.8. Limitations
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“With respect to other bodily fluids, such as saliva and urine, it has been demonstrated that the estimated levels are highly discrepant and weakly correlated to plasmatic levels (McCullough et al., 2013).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.1. Reliability of assays
What the sources say
- Not checked yetcites McCullough et al., 2013 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“they were included in some of the articles in the Psychosis subgroup (OT: 6 out of 11 (Goldman et al., 2008;Rubin et al., 2014Rubin et al., , 2013Rubin et al., , 2010;;Strauss et al., 2015;Walss-Bass et al., 2013)); ADH (4 out of 13 (Emsley et al., 1989;Ohsawa et al., 1993;Rubin et al., 2014Rubin et al., , 2013)))”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.8. Limitations
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“EIA performed without extraction yielded to values that were two orders of magnitude greater than those in extracted samples (Szeto et al., 2011) and without correlation, due to the presence of multiple adjunctive immunoreactive products besides oxytocin (Szeto et al., 2011).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.1. Reliability of assays
What the sources say
- Not checked yetcites Szeto et al., 2011 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“ADH is involved in the regulation of the hypothalamus-pituitary-adrenal (HPA) axis, which has been found to be overactive in BD (Cervantes et al., 2001;Daban et al., 2005) and MDD (Carroll et al., 1981;Dinan, 1994;Holsboer, 2000).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.6. BD and MDD
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Moreover, high levels of oxytocinase secreted by the placenta might further contribute to the final serum/plasma OT levels (Nomura et al., 2005).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.8. Limitations
What the sources say
- Not checked yetcites Nomura et al., 2005 source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The lack of significant association was secondary to high heterogeneity across individual studies, low quality and significant methodological limitations.”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4. Discussion
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Studies investigating plasma OT and ADH levels during the menstrual cycle in different species, including humans, found that these fluctuate across the ovarian cycle (Wathes and Swann, 1982).(Spruce et al., 1985).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.8. Limitations
What the sources say
- Not checked yetcites Wathes and Swann, 1982
- Not checked yetcites Spruce et al., 1985 source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, only 18% of the studies investigating OT and none of those investigating ADH analyzed the fluctuations of OT levels across the menstrual cycle phases.”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.8. Limitations
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“It is evident, as others have previously suggested (Christensen et al., 2014), that the two immunoassays are poorly correlated, thus preventing the comparison of results obtained by different research groups.”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.1. Reliability of assays
What the sources say
- Not checked yetcites Christensen et al., 2014 source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“38% of the included studies reported that participants were taking lithium salts (eTable 3).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 4.8. Limitations
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“According to the Bonferroni correction, each hypothesis has been tested at a significance level of 0.002 (CI unadjusted).”
§ Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis > 5. Conclusions
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Some, but not all, studies have shown reduced plasma oxytocin levels in children with autism spectrum disorder.6”
From Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder (2021) · cites this paper as [6]
Experimental — accuracy not yet measuredIn the citing paper
“A recent systematic review has concluded that studies using ELISA on unextracted samples have produced no convincing evidence that peripheral vasopressin or oxytocin might be reliable biomarkers in psychiatric disorders 135.”
From Measuring Oxytocin and Vasopressin: Bioassays, Immunoassays and Random Numbers (2016) · cites this paper as [135]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
MDD plasma ADH effect estimate falls outside its confidence interval
MajorThe reported Hedges' g of −0.341 is below the stated confidence interval, which runs from −0.078 to 0.759. The interval's midpoint is +0.3405, suggesting a sign error in either the estimate or the interval.
Reported -0.341 · recomputed 0.3405
“MDD (n ¼6, overall sample ¼423, Hedges' g¼ À0.341, 95% CI from À 0.078 to 0.759, p unc ¼0.111”
ASD plasma OT analysis counts four studies but lists five
MinorTable 1 lists five ASD plasma-OT samples: Modahl, Al-Ayadhi, Miller, Alabdali, and Taurines. Their sample sizes total the reported 404, but the analysis says n = 4.
“ASD (n ¼4, overall sample ¼404, Hedges' g¼ À0.576”
“(a) Taurines et al. (2014) | Germany | OT | Plasma | ASD | 36 | 19 | 10.7 | 13.6 | 0 | 0 |”
Citations
Cites
1 retracted
Gumley, A. I., Braehler, C., & MacBeth, A. M. (2014) · British Journal of Clinical Psychology · doi:10.1111/bjc.12041 · Cited by 34 · cited 3×
“Nevertheless, a recent meta-analysis examining the effects of OT on psychotic symptoms and social cognition found weak and inconsistent evidence, mainly because of methodological limitations, similarly as the ones observed by our current analysis (Gumley et al., 2014).”
RetractedCochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048 · cited 3×
“To further assess the robustness of the results, we performed sensitivity analyses by sequentially removing each study and re-running the analysis, when at least 5 studies were included (Higgins and Green, 2011).”
InfluentialMeta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099 · cited 2×
“Publication biases were tested with the Duval and Tweedie “trim and fill” method (Duval and Tweedie, 2000), when at least 3 studies were included.”
Method(2000) · Cited by 9,198
The Handbook of Research Synthesis and Meta-Analysis
(2019) · doi:10.7758/9781610448864 · Cited by 4,553 · cited 1×
“As meta-analysis of observational studies is supposed to be characterized by significant heterogeneity, random effect models were used (Cooper et al., 2009).”
MethodThe oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089 · cited 1×
“They are released in systemic circulation through the posterior pituitary gland, where they act as hormones regulating a range of physiological functions (Gimpl and Fahrenholz, 2001; Leng et al., 2015).”
Carroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181 · cited 2×
“, 2005) and MDD (Carroll et al., 1981; Dinan, 1994; Holsboer, 2000).”
Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00465-7 · Cited by 2,091 · cited 2×
“…cues (Zak et al., 2005) and has an effect on emotion recognition/theory of mind (Domes et al., 2007; Guastella et al., 2010b), fearful face processing (Evans et al., 2010), social anxiety (Heinrichs et al., 2003), paranoia (Legros et al., 1992), and trust behaviour (Baumgartner et al., 2008).”
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
Meyer-Lindenberg, A., Domes, G., Kirsch, P., & Heinrichs, M. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3044 · Cited by 1,688 · cited 1×
“These neuropeptides are associated with complex social and emotional processing in healthy people which if impaired may account for some of the symptoms present in psychiatric disorders (Meyer-Lindenberg et al., 2011).”
BackgroundPaulson, J. F., & Bazemore, S. D. (2010) · JAMA · doi:10.1001/jama.2010.605 · Cited by 1,337 · cited 2×
“Heterogeneity among study point estimates was assessed using Q statistics (Paulson and Bazemore, 2010) and the proportion of the total variability in the effect size estimates evaluated with the I(2) index (Lipsey and Wilson, 2000).”
MethodOxytocin improves “mind-reading” in humans
Domes, G., Heinrichs, M., Michel, A., Berger, C., & Herpertz, S. C. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.015 · Cited by 1,298 · cited 2×
“, 2005) and has an effect on emotion recognition/theory of mind (Domes et al., 2007; Guastella et al., 2010b), fearful face processing (Evans et al.”
BackgroundOxytocin shapes the neural circuitry of trust and trust adaptation in humans
Baumgartner, T., Heinrichs, M., Vonlanthen, A., Fischbacher, U., & Fehr, E. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.009 · Cited by 1,258 · cited 3×
“, 2004) investigated peripheral levels of ADH in first-episode, drug naïve patients and eight (Beckmann et al., 1985; Elman et al., 2003; Jobst et al., 2014; Kudoh et al., 1998; Ohsawa et al., 1993; Rubin et al., 2014; Sarai and Matsunaga, 1989; Walsh et al., 2005) in chronic patients.”
BackgroundInfluentialLandgraf, R., & Neumann, I. D. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.05.001 · Cited by 1,059 · cited 2×
“…and independent neuropeptide synthesis and vesicle routing and targeting have been shown in the somata (for peripheral secretion and somatic release) and in dendrites (for dendritic release), which might account for independent central and peripheral release patterns (Landgraf and Neumann, 2004).”
Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.
Guastella, A. J., Einfeld, S. L., Gray, K. M., Rinehart, N. J., Tonge, B. J., Lambert, T. J., & Hickie, I. B. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.020 · Cited by 962 · cited 3×
“For example, OT alters response to social cues (Zak et al., 2005) and has an effect on emotion recognition/theory of mind (Domes et al., 2007; Guastella et al., 2010b), fearful face processing (Evans et al., 2010), social anxiety (Heinrichs et al., 2003), paranoia (Legros et al., 1992), and trust…”
Dendritic peptide release and peptide-dependent behaviours
Ludwig, M., & Leng, G. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1845 · Cited by 945 · cited 8×
“…authors, about the lack of neurophysiological evidence of a direct relationship between peripheral levels of OT and ADH and their central release and activity (Grinevich et al., 2015; Kagerbauer et al., 2013; Leng and Ludwig, 2015; Ludwig and Leng, 2006; McCullough et al., 2013; Neumann, 2007).”
BackgroundInfluentialPromoting social behavior with oxytocin in high-functioning autism spectrum disorders.
Andari, E., Duhamel, J.-R., Zalla, T., Herbrecht, E., Leboyer, M., & Sirigu, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910249107 · Cited by 941 · cited 2×
“…Rutigliano et al. / Psychiatry Research 241 (2016) 207–220 217 domains, namely emotion recognition (Guastella et al., 2010a), social cognition (Andari et al., 2010), and core autistic repetitive behaviours (e.g. ordering, compulsion to tell/ask and touching) (Hollander et al., 2003), to…”
Oxytocin, vasopressin, and human social behavior
Heinrichs, M., von Dawans, B., & Domes, G. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.005 · Cited by 799 · cited 1×
“An increasing number of studies have also began to dissect the roles of OT and ADH in human social behaviour (Heinrichs et al., 2009).”
Plasma oxytocin levels in autistic children
Modahl, C., Green, L. A., Fein, D., Morris, M., Waterhouse, L., Feinstein, C., & Levin, H. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00439-3 · Cited by 728 · cited 13×
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al., 1998), Psychosis (Elman…”
InfluentialOxytocin Infusion Reduces Repetitive Behaviors in Adults with Autistic and Asperger's Disorders
Hollander, E., Novotny, S., Hanratty, M., Yaffe, R., DeCaria, C. M., Aronowitz, B. R., & Mosovich, S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300021 · Cited by 689 · cited 2×
“ordering, compulsion to tell/ask and touching) (Hollander et al., 2003), to modest (Anagnostou et al.”
Intranasal Oxytocin: Myths and Delusions
Leng, G., & Ludwig, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.05.003 · Cited by 616 · cited 4×
“…207 –220 215 G. Rutigliano et al. / Psychiatry Research 241 (2016) 207–220216 On the other hand plasma OT levels are stable, except in pregnancy (Leng and Ludwig, 2015), but may be regulated independently from central OT as suggested by converging evidence from animal studies (Ludwig et al.,…”
InfluentialOxytocin is associated with human trustworthiness
ZAK, P., KURZBAN, R., & MATZNER, W. (2005) · Hormones and Behavior · doi:10.1016/j.yhbeh.2005.07.009 · Cited by 595 · cited 2×
“For example, OT alters response to social cues (Zak et al., 2005) and has an effect on emotion recognition/theory of mind (Domes et al., 2007; Guastella et al., 2010b), fearful face processing (Evans et al., 2010), social anxiety (Heinrichs et al., 2003), paranoia (Legros et al., 1992), and trust…”
The Peptide That Binds: A Systematic Review of Oxytocin and its Prosocial Effects in Humans
MacDonald, K., & MacDonald, T. M. (2010) · Harvard Review of Psychiatry · doi:10.3109/10673220903523615 · Cited by 585 · cited 5×
“Further, peptides appear to have a short plasma half-life (1–2 min) and a slightly longer central half-life ( 30 min) (MacDonald and MacDonald, 2010).”
InfluentialPlasma oxytocin increases in the human sexual response
CARMICHAEL, M. S., HUMBERT, R., DIXEN, J., PALMISANO, G., GREENLEAF, W., & DAVIDSON, J. M. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-1-27 · Cited by 554 · cited 2×
“Originally, ADH and OT have been described as hormones, involved respectively in antidiuresis, osmolality regulation, direct vasoconstriction and hepatic glycogenolysis (Appelgren, 1982; Robertson, 2001) and labor (Husslein, 1984), lactation (Crowley, 2015), and sexual activity (Carmichael et al., 1987).”
Neuromodulation by Oxytocin and Vasopressin
Stoop, R. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.025 · Cited by 506 · cited 2×
“They are also released in the central nervous system, acting on multiple brain regions as neuromodulators and influencing a range of neurophysiological processes and behaviours (Stoop, 2012), including feeding, anxiety, aggression, social recognition and the stress/fear response to social stimuli (Hashimoto et al.”
Walum, H., Westberg, L., Henningsson, S., Neiderhiser, J. M., Reiss, D., Igl, W., Ganiban, J. M., Spotts, E. L., Pedersen, N. L., Eriksson, E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803081105 · Cited by 460
Problems with measuring peripheral oxytocin: can the data on oxytocin and human behavior be trusted?
McCullough, M. E., Churchland, P. S., & Mendez, A. J. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.018 · Cited by 416
Vasopressin V1b receptor knockout reduces aggressive behavior in male mice
Wersinger, S. R., Ginns, E. I., O'Carroll, A.-M., Lolait, S. J., & Young III, W. S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001195 · Cited by 397 · cited 2×
“Axonal and dendritic/soma release may be independently regulated by the MCNs through inhibitory mechanisms – mediated by corticosterone, GABA, endogenous opioids, the atrial natriuretic peptide and ADH itself – which selectively block the peripheral secretion (Wotjak et al., 1998).”
BackgroundMens, W. B. J., Witter, A., & Van Wimersma Greidanus, T. B. (1983) · Brain Research · doi:10.1016/0006-8993(83)90478-x · Cited by 360 · cited 1×
“Furthermore, the blood-brain barrier prevents ADH and OT to reflow into the central compartment (i. e. brain parenchyma and CSF) once they have reached the peripheral one (i. e., blood and peripheral organs) (Kagerbauer et al., 2013; Mens et al., 1983).”
Anagnostou, E., Soorya, L., Chaplin, W., Bartz, J., Halpern, D., Wasserman, S., Wang, A. T., Pepa, L., Tanel, N., Kushki, A., et al. (2012) · Molecular Autism · doi:10.1186/2040-2392-3-16 · Cited by 350
Wotjak, C. T., Ganster, J., Kohl, G., Holsboer, F., Landgraf, R., & Engelmann, M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00683-0 · Cited by 345 · cited 1×
“Axonal and dendritic/soma release may be independently regulated by the MCNs through inhibitory mechanisms – mediated by corticosterone, GABA, endogenous opioids, the atrial natriuretic peptide and ADH itself – which selectively block the peripheral secretion (Wotjak et al., 1998).”
Intracellular calcium stores regulate activity-dependent neuropeptide release from dendrites
Ludwig, M., Sabatier, N., Bull, P. M., Landgraf, R., Dayanithi, G., & Leng, G. (2002) · Nature · doi:10.1038/nature00822 · Cited by 344 · cited 2×
“Priming persisting for at least 90 min (Ludwig et al., 2002) allows peptides to survive for long enough to diffuse to distant sites.”
Glucocorticoids and the Genesis of Depressive Illness a Psychobiological Model
Dinan, T. G. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.3.365 · Cited by 344 · cited 2×
“, 2005) and MDD (Carroll et al., 1981; Dinan, 1994; Holsboer, 2000).”
Rilling, J. K., DeMarco, A. C., Hackett, P. D., Chen, X., Gautam, P., Stair, S., Haroon, E., Thompson, R., Ditzen, B., Patel, R., et al. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.09.022 · Cited by 343 · cited 2×
“ADH has been shown to alter reciprocation of cooperation in males (Rilling et al., 2014) while the ADH Avpr-1a gene, which is involved in social bonding in humans (Walum et al., 2008), has been shown to influence the money people will give to others in an economic game (Knafo et al., 2008).”
Central vasopressin and oxytocin release: regulation of complex social behaviours
VEENEMA, A., & NEUMANN, I. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00422-6 · Cited by 338 · cited 2×
“intracerebral microdialysis (Veenema and Neumann, 2008), targeted delivery of neuropeptide agonists or antagonists (Song et al.”
Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin
Szeto, A., McCabe, P. M., Nation, D. A., Tabak, B. A., Rossetti, M. A., McCullough, M. E., Schneiderman, N., & Mendez, A. J. (2011) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31821df0c2 · Cited by 330
Sex-specific influences of vasopressin on human social communication
Thompson, R. R., George, K., Walton, J. C., Orr, S. P., & Benson, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600406103 · Cited by 312 · cited 16×
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al., 1998), Psychosis (Elman…”
InfluentialAssembling the puzzle: pathways of oxytocin signaling in the brain
Grinevich, V., Knobloch-Bollmann, H. S., Eliava, M., Busnelli, M., & Chini, B. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.04.013 · Cited by 309 · cited 3×
“…authors, about the lack of neurophysiological evidence of a direct relationship between peripheral levels of OT and ADH and their central release and activity (Grinevich et al., 2015; Kagerbauer et al., 2013; Leng and Ludwig, 2015; Ludwig and Leng, 2006; McCullough et al., 2013; Neumann, 2007).”
Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients
Feifel, D., Macdonald, K., Nguyen, A., Cobb, P., Warlan, H., Galangue, B., Minassian, A., Becker, O., Cooper, J., Perry, W., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.04.039 · Cited by 308 · cited 2×
“…of two recent clinical trials of exogenous OT (intranasal administration; dose: 24 IU twice daily (Pedersen et al., 2011) and 40 IU twice daily (Feifel et al., 2010)) in patients with schizophrenia suggest a therapeutic effect across different symptom domains with good safety and tolerability…”
Pedersen, C. A., Gibson, C. M., Rau, S. W., Salimi, K., Smedley, K. L., Casey, R. L., Leserman, J., Jarskog, L. F., & Penn, D. L. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.027 · Cited by 305 · cited 2×
“Finally, the results of two recent clinical trials of exogenous OT (intranasal administration; dose: 24 IU twice daily (Pedersen et al., 2011) and 40 IU twice daily (Feifel et al.”
Knafo, A., Israel, S., Darvasi, A., Bachner‐Melman, R., Uzefovsky, F., Cohen, L., Feldman, E., Lerer, E., Laiba, E., Raz, Y., et al. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00341.x · Cited by 302 · cited 2×
“ADH has been shown to alter reciprocation of cooperation in males (Rilling et al., 2014) while the ADH Avpr-1a gene, which is involved in social bonding in humans (Walum et al., 2008), has been shown to influence the money people will give to others in an economic game (Knafo et al., 2008).”
Is oxytocin an ovarian hormone?
Wathes, D. C., & Swann, R. W. (1982) · Nature · doi:10.1038/297225a0 · Cited by 266 · cited 1×
“Studies investigating plasma OT and ADH levels during the menstrual cycle in different species, including humans, found that these fluctuate across the ovarian cycle (Wathes and Swann, 1982).”
Uzunova, G., Pallanti, S., & Hollander, E. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1085597 · Cited by 257 · cited 1×
“…there is also growing interest in the potential for synthetic neuropeptides in treatment of psychosis (for a comprehensive review see (Gumley et al., 2014)), autism spectrum disorders (ASD) (Thompson et al., 2006; Uzunova et al., 2015), and affective and anxiety disorders (Griebel et al., 2012).”
Hypothalamic-pituitary-adrenal axis and bipolar disorder
Daban, C., Vieta, E., Mackin, P., & Young, A. H. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.01.005 · Cited by 245 · cited 2×
“ADH is involved in the regulation of the hypothalamus-pituitary-adrenal (HPA) axis, which has been found to be overactive in BD (Cervantes et al., 2001; Daban et al., 2005) and MDD (Carroll et al., 1981; Dinan, 1994; Holsboer, 2000).”
The psychobiology of emotion: the role of the oxytocinergic system
Uvnäs-Moberg, K., Arn, I., & Magnusson, D. (2005) · International Journal of Behavioral Medicine · doi:10.1207/s15327558ijbm1202_3 · Cited by 238 · cited 1×
“Also long-lasting changes induced in other transmitter systems may further extend their biological activity and behavioural effects (MacDonald and MacDonald, 2010; Uvanas-Moberg et al., 2005).”
BackgroundPeripheral oxytocin is associated with reduced symptom severity in schizophrenia
Rubin, L. H., Carter, C. S., Drogos, L. L., Pournajafi‐Nazarloo, H., Sweeney, J. A., & Maki, P. M. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.09.014 · Cited by 228 · cited 3×
“, 2009) and OT levels have been shown to correlate inversely with symptomatology (including suspiciousness and paranoia) and prosociality (Rubin et al., 2010), as well as capacity to identify facial emotions (Goldman et al.”
Ryan, M. C. M., Sharifi, N., Condren, R., & Thakore, J. H. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.08.011 · Cited by 225 · cited 2×
“Three studies (Emsley et al., 1989; Rubin et al., 2013; Ryan et al., 2004) investigated peripheral levels of ADH in first-episode, drug naïve patients and eight (Beckmann et al., 1985; Elman et al., 2003; Jobst et al., 2014; Kudoh et al., 1998; Ohsawa et al., 1993; Rubin et al., 2014; Sarai and…”
Release of oxytocin within the supraoptic nucleus during the milk ejection reflex in rats
Moos, F., Poulain, D. A., Rodriguez, F., Guern�, Y., Vincent, J. D., & Richard, P. (1989) · Experimental Brain Research · doi:10.1007/bf00248916 · Cited by 221 · cited 2×
“…et al. / Psychiatry Research 241 (2016) 207–220216 On the other hand plasma OT levels are stable, except in pregnancy (Leng and Ludwig, 2015), but may be regulated independently from central OT as suggested by converging evidence from animal studies (Ludwig et al., 1994; Moos et al., 1989).”
Goldman, M. B., Marlow-O’Connor, M., Torres, I. J., & Carter, C. S. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.09.019 · Cited by 216 · cited 5×
“…in the trust-related increases in OT seen in controls (Keri et al., 2009) and OT levels have been shown to correlate inversely with symptomatology (including suspiciousness and paranoia) and prosociality (Rubin et al., 2010), as well as capacity to identify facial emotions (Goldman et al., 2008).”
InfluentialOxytocin Levels in Social Anxiety Disorder
Hoge, E. A., Pollack, M. H., Kaufman, R. E., Zak, P. J., & Simon, N. M. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00051.x · Cited by 213 · cited 1×
“…2014; Turan et al., 2013), major depressive disorder (MDD) (Goldstein et al., 2000; Ozsoy et al., 2009; Yuen et al., 2014), as well as in anxiety (Hoge et al., 2012, 2008), personality (Bertsch et al., 2013) and eating disorders (anorexia nervosa, AN and bulimia nervosa, BN) (Frank et al., 2000;…”
Kagerbauer, S. M., Martin, J., Schuster, T., Blobner, M., Kochs, E. F., & Landgraf, R. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12038 · Cited by 212 · cited 4×
“…authors, about the lack of neurophysiological evidence of a direct relationship between peripheral levels of OT and ADH and their central release and activity (Grinevich et al., 2015; Kagerbauer et al., 2013; Leng and Ludwig, 2015; Ludwig and Leng, 2006; McCullough et al., 2013; Neumann, 2007).”
InfluentialLeckman, J. F. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950100030003 · Cited by 209 · cited 2×
“…social anxiety (GSAD) (Hoge et al., 2012), borderline personality disorder (BPD) (Bertsch et al., 2013), attention deficit and hyperactivity disorder (ADHD) (Taurines et al., 2014), Tourette syndrome (TS) (Leckman et al., 1994) and Prader-Willi syndrome (PWS) (Martin et al., 1998) (eTable 4).”
InfluentialRobertson, G. L. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70207-3 · Cited by 207 · cited 2×
“…ADH and OT have been described as hormones, involved respectively in antidiuresis, osmolality regulation, direct vasoconstriction and hepatic glycogenolysis (Appelgren, 1982; Robertson, 2001) and labor (Husslein, 1984), lactation (Crowley, 2015), and sexual activity (Carmichael et al., 1987).”
Pagani, J. H., Zhao, M., Cui, Z., Williams Avram, S. K., Caruana, D. A., Dudek, S. M., & Young, W. S. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.47 · Cited by 204 · cited 2×
“, 2002), and viral gene transfer (Pagani et al., 2014)).”
Gold, P. W., Kaye, W., Robertson, G. L., & Ebert, M. (1983) · New England Journal of Medicine · doi:10.1056/nejm198305123081902 · Cited by 192 · cited 3×
“…CSF Antidiuretic Hormone in Obsessive-Compulsive Disorder Altemus et al. (1992a) 3 ⋆ / / ⋆ / / ⋆ / (b) Leckman et al. (1994) 5 ⋆ / / / ⋆⋆ ⋆ ⋆ / Overall 4.00 (71.414) CSF Antidiuretic Hormone in Anorexia Nervosa (a) Gold et al. (1983) 2 / / / / ⋆ / ⋆ / (c) Frank et al. (2000) 6 ⋆ / ⋆ ⋆ ⋆⋆ /…”
BackgroundInfluentialReduced plasma oxytocin levels in female patients with borderline personality disorder
Bertsch, K., Schmidinger, I., Neumann, I. D., & Herpertz, S. C. (2013) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.11.013 · Cited by 189 · cited 4×
“, 2012), borderline personality disorder (BPD) (Bertsch et al., 2013), attention deficit and hyperactivity disorder (ADHD) (Taurines et al.”
InfluentialAltemus, M. M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820010009002 · Cited by 187 · cited 1×
“…al. (1998) 3 / / / / ⋆⋆ / ⋆ / Elman et al. (2003) 5 ⋆ / ⋆ ⋆ / / ⋆ ⋆ Ryan et al. (2004) 6 ⋆ / / ⋆ ⋆⋆ ⋆ ⋆ / Walsh et al. (2005) 5 ⋆ / / ⋆ ⋆ ⋆ ⋆ / (b) Rubin et al. (2013) 6 ⋆ ⋆ ⋆ ⋆ ⋆ / ⋆ / (b) Jobst et al. (2014) 4 ⋆ / / / ⋆⋆ / ⋆ / (d) Rubin et al. (2014) 7 ⋆ / / ⋆ ⋆⋆ ⋆ ⋆ ⋆ Overall 4.09 (71.814) CSF…”
InfluentialThe effects of vasopressin on human facial responses related to social communication
Thompson, R. R., Gupta, S., Miller, K., Mills, S. D., & Orr, S. P. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00133-6 · Cited by 184 · cited 2×
“Research with ADH in human social cognition is less prevalent but there is evidence that intranasal ADH biases emotional face perception (Thompson et al., 2004)), enhances memory encoding of human faces (Guastella et al.”
Özsoy, S., Eşel, E., & Kula, M. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.06.034 · Cited by 168 · cited 20×
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al., 1998), Psychosis (Elman…”
InfluentialSharing secrets: oxytocin and trust in schizophrenia
Kéri, S., Kiss, I., & Kelemen, O. (2009) · Social Neuroscience · doi:10.1080/17470910802319710 · Cited by 167 · cited 2×
“In schizophrenia, patients have been shown to produce a failure in the trust-related increases in OT seen in controls (Keri et al., 2009) and OT levels have been shown to correlate inversely with symptomatology (including suspiciousness and paranoia) and prosociality (Rubin et al., 2010), as well…”
Circadian secretion of cortisol in bipolar disorder.
Cervantes, P., Gelber, S., Kin, F. N. K. N. Y., Nair, V. N. P., & Schwartz, G. J. (2001) · PubMed Central · Cited by 163
Stimuli and consequences of dendritic release of oxytocin within the brain
Neumann, I. D. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351252 · Cited by 161 · cited 2×
“…authors, about the lack of neurophysiological evidence of a direct relationship between peripheral levels of OT and ADH and their central release and activity (Grinevich et al., 2015; Kagerbauer et al., 2013; Leng and Ludwig, 2015; Ludwig and Leng, 2006; McCullough et al., 2013; Neumann, 2007).”
Merali, Z., Kent, P., Du, L., Hrdina, P. D., Palkovits, M., Faludi, G., Poulter, M. O., Bédard, T., & Anisman, H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.008 · Cited by 160 · cited 5×
“Postmortem brain tissues of patients with MDD and BD contain a greater number of ADH-immunoreactive neurons in the hypothalamic PVN (Merali et al., 2006).”
BackgroundInfluentialAnagnostou, E., Soorya, L., Brian, J., Dupuis, A., Mankad, D., Smile, S., & Jacob, S. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.049 · Cited by 155 · cited 2×
“, 2012) or null clinical improvement (Anagnostou et al., 2014).”
Ludwig, M., Callahan, M. F., Neumann, I. D., Landgraf, R., & Morris, M. (1994) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1994.tb00595.x · Cited by 155 · cited 2×
“…et al. / Psychiatry Research 241 (2016) 207–220216 On the other hand plasma OT levels are stable, except in pregnancy (Leng and Ludwig, 2015), but may be regulated independently from central OT as suggested by converging evidence from animal studies (Ludwig et al., 1994; Moos et al., 1989).”
Miller, M., Bales, K. L., Taylor, S. L., Yoon, J., Hostetler, C. M., Carter, C. S., & Solomon, M. (2013) · Autism Research · doi:10.1002/aur.1270 · Cited by 151 · cited 2×
“(a) Miller et al. (2013) 2013 USA OT Plasma ASD 75 40 35 12 12.”
InfluentialLow CSF oxytocin reflects high intent in suicide attempters
Jokinen, J., Chatzittofis, A., Hellström, C., Nordström, P., Uvnäs-Moberg, K., & Åsberg, M. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.07.016 · Cited by 143 · cited 3×
“…authors, about the lack of neurophysiological evidence of a direct relationship between peripheral levels of OT and ADH and their central release and activity (Grinevich et al., 2015; Kagerbauer et al., 2013; Leng and Ludwig, 2015; Ludwig and Leng, 2006; McCullough et al., 2013; Neumann, 2007).”
BackgroundVasopressin-oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls
Beckmann, H., Lang, R. E., & Gattaz, W. F. (1985) · Psychoneuroendocrinology · doi:10.1016/0306-4530(85)90056-3 · Cited by 138 · cited 2×
“…(1997) 4 ⋆ / / ⋆ / / ⋆ ⋆ van Londen et al. (1998) 4 ⋆ / / ⋆ / / ⋆ ⋆ Rubin et al. (1999) 5 ⋆ / / ⋆ ⋆⋆ / ⋆ / Goldstein et al. (2000) 4 ⋆ / / / ⋆ / ⋆ ⋆ Goekoop et al. (2006) 3 ⋆ / / / / / ⋆ ⋆ Overall 3.67 (71.033) CSF Antidiuretic Hormone in Psychosis (b) Beckmann et al. (1985) 3 ⋆ ⋆ / / / / ⋆ /…”
InfluentialNeuroendocrine Regulation of Lactation and Milk Production
Crowley, W. R. (2014) · Comprehensive physiology · doi:10.1002/cphy.c140029 · Cited by 135
Intranasal Arginine Vasopressin Enhances the Encoding of Happy and Angry Faces in Humans
Guastella, A. J., Kenyon, A. R., Alvares, G. A., Carson, D. S., & Hickie, I. B. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.03.014 · Cited by 130 · cited 3×
“For example, OT alters response to social cues (Zak et al., 2005) and has an effect on emotion recognition/theory of mind (Domes et al., 2007; Guastella et al., 2010b), fearful face processing (Evans et al., 2010), social anxiety (Heinrichs et al., 2003), paranoia (Legros et al., 1992), and trust…”
Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders
Rubin, L. H., Carter, C. S., Bishop, J. R., Pournajafi-Nazarloo, H., Drogos, L. L., Hill, S. K., Ruocco, A. C., Keedy, S. K., Reilly, J. L., Keshavan, M. S., et al. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbu027 · Cited by 127 · cited 11×
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al., 1998), Psychosis (Elman…”
InfluentialLawson, E. A., Donoho, D. A., Blum, J. I., Meenaghan, E. M., Misra, M., Herzog, D. B., Sluss, P. M., Miller, K. K., & Klibanski, A. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06617 · Cited by 124
Lawson, E. A., Holsen, L. M., Santin, M., Meenaghan, E. M., Eddy, K. T., Becker, A. E., Herzog, D. B., Goldstein, J. M., & Klibanski, A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1702 · Cited by 121
Drug-Induced Diabetes Insipidus
Bendz, H., & Aurell, M. (1999) · Drug Safety · doi:10.2165/00002018-199921060-00002 · Cited by 120
The maternal brain: an organ with peripartal plasticity
Hillerer, K. M., Jacobs, V. R., Fischer, T., & Aigner, L. (2014) · Neural Plasticity · doi:10.1155/2014/574159 · Cited by 120
Oxytocin in schizophrenia: a review of evidence for its therapeutic effects
MacDonald, K. S., & Feifel, D. (2011) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2011.00634.x · Cited by 117 · cited 1×
“Administration of OT either intracerebrally or subcutaneously effectively reverted behavioural deficits in rodent models of schizophrenia (Macdonald and Feifel, 2012).”
BackgroundAssociation of social and cognitive impairment and biomarkers in autism spectrum disorders
Alabdali, A., Al-Ayadhi, L., & El-Ansary, A. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-4 · Cited by 117 · cited 14×
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al., 1998), Psychosis (Elman…”
InfluentialCSF oxytocin in anorexia nervosa and bulimia nervosa: clinical and pathophysiologic considerations
Demitrack, M. A., Lesem, M. D., LISTWAK, S. J., Brandt, H., Jimerson, D. C., & Gold, P. W. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.7.882 · Cited by 116 · cited 3×
“(a) Demitrack et al. (1990) 1990 USA OT CSF AN 25 14 11 24.”
InfluentialSong, Z., McCann, K. E., McNeill, J. K., Larkin, T. E., Huhman, K. L., & Albers, H. E. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.08.005 · Cited by 111 · cited 1×
“…manipulate central OT and ADH levels and their effects on behaviour (e.g. intracerebral microdialysis (Veenema and Neumann, 2008), targeted delivery of neuropeptide agonists or antagonists (Song et al., 2014), gene knockout (Wersinger et al., 2002), and viral gene transfer (Pagani et al., 2014)).”
Role of oxytocin signaling in the regulation of body weight
Blevins, J. E., & Ho, J. M. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9260-x · Cited by 108 · cited 2×
“…levels as biomarkers of AN is weakened by the global hypothalamic-pituitary dysfunction, the impact of fluid and sodium restriction and purging behaviours observed in AN and the putative role of the two hormones in the regulation of the gut brain axis and energy homeostasis (Blevins and Ho, 2013).”
Cerebrospinal-fluid vasopressin in neurological and psychiatric-disorders
Sorensen, P. S., Gjerris, A., & Hammer, M. (1985) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.1.50 · Cited by 103 · cited 19×
“Plasma oxytocin levels in autistic children.”
InfluentialYuen, K. W., Garner, J. P., Carson, D. S., Keller, J., Lembke, A., Hyde, S. A., Kenna, H. A., Tennakoon, L., Schatzberg, A. F., & Parker, K. J. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.12.012 · Cited by 99
The Role of Oxytocin in Neuropsychiatric Disorders
Marazziti, D., & Dell’Osso, M. C. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708783885291 · Cited by 99
Silva, S. M., Madeira, M. D., Ruela, C., & Paula-Barbosa, M. M. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03261-9 · Cited by 98 · cited 2×
“%) failed to control for alcohol intake (not applicable to 2 studies which had recruited only children), which was reported to induce degeneration in numerous neurons in the hypothalamic magnocellular system in rats (Silva et al., 2002).”
Oxytocin decreases aversion to angry faces in an associative learning task
Evans, S., Shergill, S. S., & Averbeck, B. B. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.110 · Cited by 97 · cited 2×
“, 2010b), fearful face processing (Evans et al., 2010), social anxiety (Heinrichs et al.”
Sasayama, D., Hattori, K., Teraishi, T., Hori, H., Ota, M., Yoshida, S., Arima, K., Higuchi, T., Amano, N., & Kunugi, H. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.016 · Cited by 96 · cited 2×
“%) failed to control for alcohol intake (not applicable to 2 studies which had recruited only children), which was reported to induce degeneration in numerous neurons in the hypothalamic magnocellular system in rats (Silva et al., 2002).”
BackgroundOxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients
Jobst, A., Dehning, S., Ruf, S., Notz, T., Buchheim, A., Henning-Fast, K., Meißner, D., Meyer, S., Bondy, B., Müller, N., et al. (2014) · Acta Neuropsychiatrica · doi:10.1017/neu.2014.20 · Cited by 89
Arginine Vasopressin Is Associated with Hypercortisolemia and Suicide Attempts in Depression
Inder, W. J., Donald, R. A., Prickett, T. C. R., FRAMPTON, C. M. A., Sullivan, P. F., Mulder, R., & Joyce, P. R. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00301-6 · Cited by 89
Cerebrospinal fluid levels of oxytocin in Prader–Willi syndrome: a preliminary report
Martin, A., State, M., Anderson, G. M., Kaye, W. M., Hanchett, J. M., McConaha, C. W., North, W. G., & Leckman, J. F. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00190-5 · Cited by 89 · cited 3×
“, 1994) and Prader-Willi syndrome (PWS) (Martin et al., 1998) (eTable4).”
Parent–child interaction and oxytocin production in pre-schoolers with autism spectrum disorder
Feldman, R., Golan, O., Hirschler‐Guttenberg, Y., Ostfeld‐Etzion, S., & Zagoory‐Sharon, O. (2014) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.113.137513 · Cited by 86
Leng, G., Pineda, R., Sabatier, N., & Ludwig, M. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0087 · Cited by 85 · cited 1×
“They are released in systemic circulation through the posterior pituitary gland, where they act as hormones regulating a range of physiological functions (Gimpl and Fahrenholz, 2001; Leng et al., 2015).”
Glovinsky, D., Kalogeras, K. T., Kirch, D. G., Suddath, R. L., & Wyatt, R. (1994) · Schizophrenia Research · doi:10.1016/0920-9964(94)90021-3 · Cited by 84
Cui, S.-S., Bowen, R. C., Gu, G.-B., Hannesson, D. K., Yu, P. H., & Zhang, X. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09867.2001 · Cited by 84 · cited 1×
“As regard OT, preclinical studies in rats found that a systemic injection of lithium leads to a significant elevation of peripheral OT levels (Cui et al., 2001; You et al., 2001).”
Rocchetti, M., Radua, J., Paloyelis, Y., Xenaki, L., Frascarelli, M., Caverzasi, E., Politi, P., & Fusar‐Poli, P. (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12185 · Cited by 83 · cited 1×
“During pregnancy dramatic structural and functional changes occur in the OT system of the mother's brain (Hillerer et al., 2014; Rocchetti et al., 2014).”
Self-citationChanges in cerebrospinal fluid neurochemistry during pregnancy
Altemus, M., Fong, J., Yang, R., Damast, S., Luine, V., & Ferguson, D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.06.002 · Cited by 83 · cited 2×
“In humans no correlation was found between central and plasma OT in pregnant women (Altemus et al., 2004) and suicide attempters (Jokinen et al., 2012).”
VARIATION IN OSMOREGULATION OF ARGININE VASOPRESSIN DURING THE HUMAN MENSTRUAL CYCLE
SPRUCE, B. A., BAYLIS, P. H., BURD, J., & WATSON, M. J. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb01062.x · Cited by 82 · cited 1×
“(Spruce et al., 1985).”
Griebel, G., Beeské, S., & Stahl, S. M. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12m07804 · Cited by 81 · cited 3×
“…there is also growing interest in the potential for synthetic neuropeptides in treatment of psychosis (for a comprehensive review see (Gumley et al., 2014)), autism spectrum disorders (ASD) (Thompson et al., 2006; Uzunova et al., 2015), and affective and anxiety disorders (Griebel et al., 2012).”
BackgroundMethodPitts, A. F., Samuelson, S. D., Meller, W. H., Bissette, G., Nemeroff, C. B., & Kathol, R. G. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00229-a · Cited by 79 · cited 1×
“…(1977) 1 / / / / / / ⋆ / (c) Rubin et al. (2014) 7 ⋆ / / ⋆ ⋆⋆ ⋆ ⋆ ⋆ Overall 4.00 (74.243) CSF Antidiuretic Hormone in Major Depressive Disorder (a) (Sorensen et al. (1985) 2 ⋆ / / / / / ⋆ / (b) Pitts et al. (1995) 4 ⋆ / / ⋆ / / ⋆ ⋆ Heuser et al. (1998) 4 ⋆ / / ⋆ / ⋆ ⋆ / Overall 3.33 (71.155)…”
InfluentialPlasma arginine vasopressin and motor activity in major depression
van Londen, L., KERKHOF, G. A., van den Berg, F., Goekoop, J. G., Zwinderman, A. H., Frankhuijzen-Sierevogel, A. C., Wiegant, V. M., & de Wied, D. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)80433-7 · Cited by 79 · cited 5×
“van Londen et al. (1998) 1998 The Netherlands ADH Plasma MDD 89 52 37 44.”
InfluentialNormal CSF oxytocin and NPY levels in OCD
Altemus, M. M., Jacobson, K. R., DeBellis, M. D., Kling, M. A., Pigott, T. A., Murphy, D. L., & Gold, P. W. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00263-7 · Cited by 78
Bendz, H., Sjödin, I., & Aurell, M. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.3.457 · Cited by 74 · cited 1×
“…lithium exerts adverse effects on the kidney, leading to nephrogenic diabetes insipidus (NDI) in up to 10% of the patients on long term treatment (Bendz and Aurell, 1999; Bendz et al., 1996), which may be expected to be associated with a compensatory increase in ADH release (Watson et al., 2007).”
Chang, S. W. C., & Platt, M. L. (2014) · Brain Research · doi:10.1016/j.brainres.2013.11.006 · Cited by 71 · cited 1×
“Evidence from animal studies has demonstrated the significant role that OT and ADH play in the regulation of social behaviour and cognition (Chang and Platt, 2014).”
Altered oxytocin and vasopressin levels in autistic children in Central Saudi Arabia
AL-Ayadhi, L. Y. (2005) · Neurosciences · doi:10.17712/1658-3183.1311 · Cited by 71 · cited 2×
“…2012, 2008), personality (Bertsch et al., 2013) and eating disorders (anorexia nervosa, AN and bulimia nervosa, BN) (Frank et al., 2000; Lawson et al., 2011, 2012), with highly heterogeneous and conflicting results (Al-Ayadhi, 2005; Alabdali et al., 2014; Emsley et al., 1989; Watson et al., 2007).”
BackgroundInfluentialChristensen, J. C., Shiyanov, P. A., Estepp, J. R., & Schlager, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116172 · Cited by 69 · cited 3×
“Since the main methodological concern specifically regards the use of extraction (Christensen et al., 2014), we performed a sensitivity analysis on the studies investigating serum/plasma ADH levels in Psychosis, which seemed to confirm that the extraction technique could have had an effect on the…”
Taurines, R., Schwenck, C., Lyttwin, B., Schecklmann, M., Jans, T., Reefschläger, L., Geissler, J. M., Gerlach, M., & Romanos, M. (2014) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-014-0145-y · Cited by 66
May oxytocin be a trait marker for bipolar disorder?
Turan, T., Uysal, C., Asdemir, A., & Kılıç, E. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.07.017 · Cited by 66 · cited 2×
“, 2013), bipolar disorder (BD) (Rubin et al., 2014; Turan et al., 2013), major depressive disorder (MDD) (Goldstein et al.”
Rubin, L. H., Carter, C. S., Bishop, J. R., Pournajafi‐Nazarloo, H., Harris, M. S. H., Hill, S. K., Reilly, J. L., & Sweeney, J. A. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.01.019 · Cited by 65
Pagel, T., Baldessarini, R. J., Franklin, J. G., & Baethge, C. (2013) · Bipolar Disorders · doi:10.1111/bdi.12057 · Cited by 64 · cited 2×
“…example, despite evidence that patients with schizoaffective psychoses may have clear distinctive features as compared to schizophrenic psychoses (Pagel et al., 2013), they were included in some of the articles in the Psychosis subgroup (OT: 6 out of 11 (Goldman et al., 2008; Rubin et al., 2014,…”
Walsh, P., Spelman, L., Sharifi, N., & Thakore, J. H. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2004.11.003 · Cited by 61
Frank, G., Kaye, W. H., Altemus, M. M., & Greeno, C. G. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00243-2 · Cited by 60 · cited 5×
“A comprehensive systematic review and preliminary meta-analysis Rutigliano Graziaa,b,1, Rocchetti Matteoa,c,1, Paloyelis Yannisd, Gilleen Jamesa,f, Sardella Albertoa, Cappucciati Marcoa,c, Palombini Erikaa,c, Dell’Osso Lilianab, Caverzasi Edgardoc, Politi Pierluigic, McGuire Philipa, Fusar-Poli Paoloa,e,n a Department…”
InfluentialChronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro
Altemus, M. M., Cizza, G., & Gold, P. W. (1992) · Brain Research · doi:10.1016/0006-8993(92)91326-a · Cited by 60 · cited 1×
“…al. (1998) 3 / / / / ⋆⋆ / ⋆ / Elman et al. (2003) 5 ⋆ / ⋆ ⋆ / / ⋆ ⋆ Ryan et al. (2004) 6 ⋆ / / ⋆ ⋆⋆ ⋆ ⋆ / Walsh et al. (2005) 5 ⋆ / / ⋆ ⋆ ⋆ ⋆ / (b) Rubin et al. (2013) 6 ⋆ ⋆ ⋆ ⋆ ⋆ / ⋆ / (b) Jobst et al. (2014) 4 ⋆ / / / ⋆⋆ / ⋆ / (d) Rubin et al. (2014) 7 ⋆ / / ⋆ ⋆⋆ ⋆ ⋆ ⋆ Overall 4.09 (71.814) CSF…”
InfluentialGoldman, M. B. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.06.004 · Cited by 59 · cited 2×
“It has been argued that psychotic exacerbations may be concurrent with a transient reset of the osmostasis for ADH secretion, elevated plasma levels of the neuropeptide and eventually water imbalance, as an epiphenomenon of dysfunctions in hypothalamic pituitary adrenal (HPA) axis response to psychological stimuli(Gol…”
BackgroundFujisawa, T. X., Tanaka, S., Saito, D. N., Kosaka, H., & Tomoda, A. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00295 · Cited by 59 · cited 2×
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al.,…”
Nomura, S., Ito, T., Yamamoto, E., Sumigama, S., Iwase, A., Okada, M., Shibata, K., Ando, H., Ino, K., Kikkawa, F., et al. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.04.006 · Cited by 58 · cited 1×
“Moreover, high levels of oxytocinase secreted by the placenta might further contribute to the final serum/plasma OT levels (Nomura et al., 2005).”
Rubín, R. T., O’Toole, S. M., Rhodes, M. E., Sekula, L. K., & Czambel, R. K. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00085-2 · Cited by 58 · cited 1×
“…4 ⋆ / / ⋆ / ⋆ ⋆ / Overall 3.33 (71.155) Plasma/Serum Antidiuretic Hormone in Major Depressive Disorder (b) Sorensen et al. (1985) 2 ⋆ / / / / / ⋆ / Inder et al. (1997) 4 ⋆ / / ⋆ / / ⋆ ⋆ van Londen et al. (1998) 4 ⋆ / / ⋆ / / ⋆ ⋆ Rubin et al. (1999) 5 ⋆ / / ⋆ ⋆⋆ / ⋆ / Goldstein et al. (2000) 4…”
InfluentialHoge, E. A., Lawson, E. A., Metcalf, C. A., Keshaviah, A. P., Zak, P. J., Pollack, M. H., & Simon, N. M. (2012) · Depression and Anxiety · doi:10.1002/da.21973 · Cited by 57 · cited 4×
“We did not perform analyses on diagnoses where there was only one study available: generalized social anxiety (GSAD) (Hoge et al., 2012), borderline personality disorder (BPD) (Bertsch et al., 2013), attention deficit and hyperactivity disorder (ADHD) (Taurines et al., 2014), Tourette syndrome (TS)…”
InfluentialAntipsychotic drugs and plasma vasopressin in normals and acute schizophrenic patients
Raskind, M. A., COURTNEY, N., Murburg, M. M., Backus, F. I., Bokan, J. A., Ries, R. K., Dorsa, D. M., & Weitzman, R. E. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90167-3 · Cited by 56 · cited 2×
“Neuroleptics have also been reported to normalise raised ADH plasma levels in patients with schizophrenia (Raskind et al., 1987).”
BackgroundPlasma, salivary, and urinary oxytocin in anorexia nervosa: A pilot study
Hoffman, E. R., Brownley, K. A., Hamer, R. M., & Bulik, C. M. (2012) · Eating Behaviors · doi:10.1016/j.eatbeh.2012.02.004 · Cited by 55 · cited 2×
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al.,…”
Walss‐Bass, C., Fernandes, J. M., Roberts, D. L., Service, H., & Velligan, D. I. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.04.003 · Cited by 53 · cited 3×
“, 2013), they were included in some of the articles in the Psychosis subgroup (OT: 6 out of 11 (Goldman et al., 2008; Rubin et al., 2014, 2013, 2010; Strauss et al., 2015; Walss-Bass et al., 2013)); ADH (4 out of 13 (Emsley et al.”
Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia
Strauss, G. P., Keller, W. R., Koenig, J. I., Gold, J. M., Frost, K. H., & Buchanan, R. W. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.034 · Cited by 51 · cited 2×
“, 2013), they were included in some of the articles in the Psychosis subgroup (OT: 6 out of 11 (Goldman et al., 2008; Rubin et al., 2014, 2013, 2010; Strauss et al., 2015; Walss-Bass et al., 2013)); ADH (4 out of 13 (Emsley et al.”
Goekoop, J. G., de Winter, R. F. P., de Rijk, R., Zwinderman, K. H., Frankhuijzen-Sierevogel, A. C., & Wiegant, V. M. (2006) · Psychiatry Research · doi:10.1016/j.psychres.2005.09.003 · Cited by 49 · cited 1×
“…Hormone in Major Depressive Disorder (b) Sorensen et al. (1985) 2 ⋆ / / / / / ⋆ / Inder et al. (1997) 4 ⋆ / / ⋆ / / ⋆ ⋆ van Londen et al. (1998) 4 ⋆ / / ⋆ / / ⋆ ⋆ Rubin et al. (1999) 5 ⋆ / / ⋆ ⋆⋆ / ⋆ / Goldstein et al. (2000) 4 ⋆ / / / ⋆ / ⋆ ⋆ Goekoop et al. (2006) 3 ⋆ / / / / / ⋆ ⋆ Overall…”
Reduced Plasma Apelin Levels in Patients with Autistic Spectrum Disorder
Boso, M., Emanuele, E., Politi, P., Pace, A., Arra, M., Nemi, S. U. D., & Barale, F. (2006) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.08.003 · Cited by 43 · cited 3×
“…et al./ Psychiatry R esearch 241 (2016) 207 –220 214 Plasma/Serum Antidiuretic Hormone in Autism Spectrum Disorder (b) Al-Ayadhi (2005) 3 ⋆ / / / ⋆ / ⋆ / Boso et al. (2007) 7 ⋆ / ⋆ ⋆ ⋆ ⋆ ⋆ ⋆ (b) Miller et al. (2013) 4 ⋆ / / / ⋆ / ⋆ ⋆ Overall 4.67 (72.082) Plasma/Serum Antidiuretic Hormone in…”
InfluentialSelf-citationPlasma Levels of Antidiuretic Hormone in Patients Receiving Prolonged Lithium Therapy
Padfield, P. L., Park, S. J., Morton, J. J., et al. (1977) · The British Journal of Psychiatry · doi:10.1192/bjp.130.2.144 · Cited by 38 · cited 2×
“R utigliano et al./ Psychiatry R esearch 241 (2016) 207 –220 214 Plasma/Serum Antidiuretic Hormone in Autism Spectrum Disorder (b) Al-Ayadhi (2005) 3 ⋆ / / / ⋆ / ⋆ / Boso et al. (2007) 7 ⋆ / ⋆ ⋆ ⋆ ⋆ ⋆ ⋆ (b) Miller et al. (2013) 4 ⋆ / / / ⋆ / ⋆ ⋆ Overall 4.67 (72.082) Plasma/Serum Antidiuretic Hormone in Bipolar Disord…”
InfluentialNeurohypophyseal Peptides and Psychopathology
Legros, J. J. (2008) · Hormone Research · doi:10.1159/000182396 · Cited by 37 · cited 2×
“, 2003), paranoia (Legros et al., 1992), and trust behaviour (Baumgartner et al.”
Impaired osmoregulation in anorexia nervosa: a case-control study
Evrard, F., da Cunha, M. P., Lambert, M. J., & Devuyst, O. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh507 · Cited by 34 · cited 2×
“R utigliano et al./ Psychiatry R esearch 241 (2016) 207 –220 214 Plasma/Serum Antidiuretic Hormone in Autism Spectrum Disorder (b) Al-Ayadhi (2005) 3 ⋆ / / / ⋆ / ⋆ / Boso et al. (2007) 7 ⋆ / ⋆ ⋆ ⋆ ⋆ ⋆ ⋆ (b) Miller et al. (2013) 4 ⋆ / / / ⋆ / ⋆ ⋆ Overall 4.67 (72.082) Plasma/Serum Antidiuretic Hormone in Bipolar Disord…”
InfluentialNeuroendocrine Regulation of Lactation and Milk Production
Crowley, W. R. (2015) · Comprehensive physiology · doi:10.1002/j.2040-4603.2015.tb00607.x · Cited by 34 · cited 2×
“…ADH and OT have been described as hormones, involved respectively in antidiuresis, osmolality regulation, direct vasoconstriction and hepatic glycogenolysis (Appelgren, 1982; Robertson, 2001) and labor (Husslein, 1984), lactation (Crowley, 2015), and sexual activity (Carmichael et al., 1987).”
Effects of Acute Metabolic Stress on the Peripheral Vasopressinergic System in Schizophrenia
Elman, I., Lukas, S. E., Shoaf, S. E., Rott, D., Adler, C. M., & Breier, A. F. (2003) · Journal of Psychopharmacology · doi:10.1177/02698811030173014 · Cited by 28 · cited 5×
“…/ / / / ⋆ / Overall 2.50 (70.707) Plasma/Serum Antidiuretic Hormone in Psychosis (d) Sorensen et al. (1985) 2 ⋆ / / / / / ⋆ / Emsley et al. (1989) 2 / / / / / / ⋆ ⋆ Sarai and Matsunaga (1989) 2 ⋆ / / / / / ⋆ / Ohsawa et al. (1993) 3 ⋆ / / / ⋆ / ⋆ / Kudoh et al. (1998) 3 / / / / ⋆⋆ / ⋆ / Elman et…”
InfluentialWater excretion and plasma vasopressin in psychotic disorders
Emsley, R. A., Potgieter, A., Taljaard, F. J. J., et al. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.2.250 · Cited by 28 · cited 5×
“…(Pagel et al., 2013), they were included in some of the articles in the Psychosis subgroup (OT: 6 out of 11 (Goldman et al., 2008; Rubin et al., 2014, 2013, 2010; Strauss et al., 2015; Walss-Bass et al., 2013)); ADH (4 out of 13 (Emsley et al., 1989; Ohsawa et al., 1993; Rubin et al., 2014, 2013)).”
BackgroundInfluentialPathophysiological function of oxytocin secreted by neuropeptides: A mini review
Hashimoto, H., Uezono, Y., & Ueta, Y. (2012) · Pathophysiology · doi:10.1016/j.pathophys.2012.07.005 · Cited by 24 · cited 2×
“They are also released in the central nervous system, acting on multiple brain regions as neuromodulators and influencing a range of neurophysiological processes and behaviours (Stoop, 2012), including feeding, anxiety, aggression, social recognition and the stress/fear response to social stimuli (Hashimoto et al., 20…”
Oxytocin mediates the inhibitory action of acute lithium on the morphine dependence in rats
You, Z. D., Li, J. H., Song, C. Y., Lu, C. L., & He, C. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(01)00272-3 · Cited by 23 · cited 1×
“As regard OT, preclinical studies in rats found that a systemic injection of lithium leads to a significant elevation of peripheral OT levels (Cui et al., 2001; You et al., 2001).”
BackgroundLithium, arginine vasopressin and the dex/CRH test in mood disordered patients
Watson, S., Gallagher, P., Smith, M. S., Young, A. H., & Ferrier, I. N. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.02.010 · Cited by 23 · cited 2×
“, 2014), gene knockout (Wersinger et al., 2002), and viral gene transfer (Pagani et al.”
BackgroundChapter 30 Neurohypophyseal peptides and psychopathology
Legros, J. J., & Ansseau, M. (1992) · Progress in brain research · doi:10.1016/s0079-6123(08)64589-6 · Cited by 21
Atrial natriuretic peptide and arginine vasopressin secretion in schizophrenic patients
Ohsawa, H., Kishimoto, T., Shimayoshi, N., et al. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03426.x · Cited by 18 · cited 26×
“Specifically, plasma/serum (Rubin et al., 2014), saliva (Fujisawa et al., 2014), urine (Hoffman et al., 2012) or cerebrospinal fluid (CSF) (Sasayama et al., 2012) OT and ADH levels have been recently tested as putative biomarkers in ASD (Alabdali et al., 2014; Boso et al., 2007; Modahl et al., 1998), Psychosis (Elman…”
BackgroundInfluentialKudoh, A., Kudo, M., Ishihara, H., et al. (1998) · Neuropsychobiology · doi:10.1159/000026498 · Cited by 14 · cited 3×
“, 2004) investigated peripheral levels of ADH in first-episode, drug naïve patients and eight (Beckmann et al., 1985; Elman et al., 2003; Jobst et al., 2014; Kudoh et al., 1998; Ohsawa et al., 1993; Rubin et al., 2014; Sarai and Matsunaga, 1989; Walsh et al., 2005) in chronic patients.”
BackgroundInfluential[The importance of oxytocin and prostaglandins to the mechanism of labor in humans].
Husslein, P. W. (1984) · PubMed · Cited by 13
ADH secretion in schizophrenic patients on antipsychotic drugs
Sarai, M., & Matsunaga, H. (1989) · Biological Psychiatry · doi:10.1016/0006-3223(89)90082-6 · Cited by 11
Elevated plasma thymopoietin associated with therapeutic nonresponsiveness in major depression
Goldstein, G., Fava, M., Culler, M. D., et al. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00246-8 · Cited by 8 · cited 3×
“, 2013), major depressive disorder (MDD) (Goldstein et al., 2000; Ozsoy et al., 2009; Yuen et al., 2014), as well as in anxiety (Hoge et al.”
InfluentialHeuser, I., Bissette, G., Dettling, M., Schweiger, U., Gotthardt, U., Schmider, J., Lammers, C.-H., Nemeroff, C. B., & Holsboer, F. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)8:2
Flagged first, then by citations
8 of the 148 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The oxytocin receptor: from intracellular signaling to behavior
Jurek, B., & Neumann, I. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00031.2017 · Cited by 999
Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder
Sikich, L., Kolevzon, A., King, B. H., McDougle, C. J., Sanders, K. B., Kim, S.-J., Spanos, M., Chandrasekhar, T., Trelles, M. D. P., Rockhill, C. M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2103583 · Cited by 298
Valstad, M., Alvares, G. A., Egknud, M., Matziorinis, A. M., Andreassen, O. A., Westlye, L. T., & Quintana, D. S. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.017 · Cited by 277
Kim, J. Y., Son, M. J., Son, C. Y., Radua, J., Eisenhut, M., Gressier, F., Koyanagi, A., Carvalho, A. F., Stubbs, B., Solmi, M., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30181-6 · Cited by 271
Self-citationLee, M. R., Scheidweiler, K. B., Diao, X. X., Akhlaghi, F., Cummins, A., Huestis, M. A., Leggio, L., & Averbeck, B. B. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.27 · Cited by 235
Metadata
- Authors
- Rutigliano, G., Rocchetti, M., Paloyelis, Y., Gilleen, J., Sardella, A., Cappucciati, M., Palombini, E., Dell’Osso, L., Caverzasi, E., Politi, P., McGuire, P., & Fusar-Poli, P.
- Affiliations
- University of Pisa (IT)
- King's College London (GB)
- University of Pavia (IT)
- ORCID
- Venue
- Psychiatry Research
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 241
- Pages
- 207-220
- ISSN
- 0165-1781 (ISSN-L)
- OpenAlex
- W2346907797
- Semantic Scholar
- b0170825c65f1ff6ded651e1a64ce45a933e7750
- Cited by
- 149
- References
- 148
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 11 · 2023: 15 · 2022: 19 · 2021: 17 · 2020: 19 · 2019: 12 · 2018: 21 · 2017: 19 · 2016: 3
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Psychiatry Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Funders
- ESRC (ES/K009400/1)
- NARSAD
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- vasopressin, biomarkers, mental illness, saliva, plasma, serum, cerebrospinal fluid, urine, anorexia nervosa, methodological heterogeneity, study quality
- MeSH terms
- Mental Disorders, Humans, Oxytocin, Vasopressins, Reproducibility of Results, Biomarkers
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-08, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-08 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review